Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study)

Diabetic kidney disease (DKD) is a devastating complication that affects an estimated third of patients with type 1 diabetes mellitus (DM). There is no cure once the disease is diagnosed, but early treatment at a sub-clinical stage can prevent or at least halt the progression. DKD is clinically diag...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Kloet, F. M., Tempels, F. W. A., Ismail, N., van der Heijden, R., Kasper, P. T., Rojas-Cherto, M., van Doorn, R., Spijksma, G., Koek, M., van der Greef, J., Mäkinen, V. P., Forsblom, C., Holthöfer, H., Groop, P. H., Reijmers, T. H., Hankemeier, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258399/
https://www.ncbi.nlm.nih.gov/pubmed/22279428
http://dx.doi.org/10.1007/s11306-011-0291-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258399/
https://www.ncbi.nlm.nih.gov/pubmed/22279428
http://dx.doi.org/10.1007/s11306-011-0291-6

Ejemplares similares